Skip to main content
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.366
+0.002 (0.55%)
At close: Mar 9, 2026

Biomark Diagnostics Revenue

Biomark Diagnostics had revenue of 6.92K CAD in the quarter ending December 31, 2025, a decrease of -82.07%. This brings the company's revenue in the last twelve months to 91.77K, down -40.80% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.

Revenue (ttm)
91.77K CAD
Revenue Growth
-40.80%
P/S Ratio
671.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
38.25M EUR

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025154.22K-9.00K-5.52%
Mar 31, 2024163.22K9.73K6.34%
Mar 31, 2023153.49K109.56K249.38%
Mar 31, 202243.93K--
Mar 31, 2021---
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- 1.22B
OTRS AG 12.08M
Fair Value REIT-AG 28.37M
U.C.A. Aktiengesellschaft 690.26K
edding AG 149.67M
SBF AG 46.20M
Enapter AG 22.54M
Fernheizwerk Neukölln Aktiengesellschaft 66.35M
Revenue Rankings

Biomark Diagnostics News

More News